GMR Solutions Inc. (GMRS) Q3 2026 earnings review

GMR Solutions beats summer profit plans, but keeps annual target

GMR Solutions, the largest US ambulance and medical helicopter operator, earned much more operating profit this summer than its own second-half plan pointed to, yet it left its full-year profit target unchanged. Third-quarter revenue rose 6% from a year ago to $1.60 billion as higher prices per ambulance ride and 51% growth in nurse phone triage offset weather-cancelled helicopter flights. Chief executive Nick Loporcaro kept the full-year Adjusted EBITDA target at $1.14 billion to $1.20 billion while trimming the middle of the revenue plan by $60 million, which by our math leaves fourth-quarter operating profit falling almost 40% from the third quarter.

At a glance
Same-market revenue growth+6.0% up from +3.8% in Q2
Adjusted EBITDA (operating profit ex one-offs)$356.6M +4.2% from a year ago (22.3% margin)
Profit per share, excluding one-offs$0.64 −22.0% from a year ago on +63% share count
Full-year outlookEBITDA held revenue midpoint trimmed $60M to $5,975M

⚖️ Verdict: ⚪ Neutral

The standing case is unchanged because a strong summer quarter was paired with an implied fourth-quarter drop that leaves full-year profit exactly where it started. On the positive side, emergency ambulance rides sped up while nurse triage grew, and a $200 million loan payoff cut quarterly interest bills by 37%. On the negative side, warrant dilution from the May listing pushed profit per share excluding one-offs down 22%, and beating the second-half margin pace in Q3 only proved the prior plan was cautious.

The question now is whether the weak fourth-quarter profit implied by the unchanged outlook is routine winter caution after a summer beat or a real jump in fuel and wage costs. If management is simply leaving a cushion after earning $357 million in Q3, full-year profit will top the range; if costs are rising, margins will drop toward 15%. Fourth-quarter Adjusted EBITDA and the call's breakdown of prior-period billing collections will tell.

🐂 Bull Case

🟢🟢 new MARGIN

Operating Profit Topped the Second-Half Plan

GMR Solutions, the largest ambulance and medical helicopter operator in the United States, earned far more in the third quarter than its full-year outlook pointed to. Finance chief Brian Tierney said "continued improvement in revenue per transport and disciplined cost management helped us absorb these headwinds" from fuel and weather. By our math, the prior full-year plan implied about $288 million of quarterly Adjusted EBITDA, which is operating profit before interest, taxes, depreciation and one-offs.

  • Adjusted EBITDA: $356.6 million, up 4.2% from a year ago and 25.3% from the second quarter
  • Adjusted EBITDA margin: 22.3% of revenue, 3.7 percentage points above the second-half rate implied by the prior plan
  • Employee wages, benefits and taxes: 50.2% of revenue, down 1.1 percentage points from 51.3% a year ago
  • Net revenue per ambulance transport: $1,426, up 3.0% from a year ago and 4.1% from the second quarter

The beat matters because third-quarter results carried the full weight of higher fuel bills and tougher comparisons from prior-year billing collections. Lower labor costs as a share of sales and higher revenue per ride paid for those pressures. Under our rules, beating what the prior outlook implied proves the summer forecast was cautious, not that fourth-quarter cost pressures have disappeared.

What to watch: the out-of-period billing collection adjustment in the quarterly filing. A small adjustment would confirm that everyday ambulance pricing and wage discipline drove the 22.3% margin.

🟢 strengthening PRODUCT

Emergency Rides and Nurse Triage Both Accelerated

Chief executive Nick Loporcaro highlighted "momentum we are seeing in Nurse Navigation and new market growth" alongside expanding emergency ambulance rides. Nurse Navigation is GMR's phone triage service that directs lower-risk 911 callers to clinics or virtual care instead of dispatching an ambulance. Critics worried that diverting 911 calls would shrink the company's core ambulance volume, while supporters argued it would free up crews for higher-paying emergency calls.

This quarter supported the bull argument because both triage calls and emergency ambulance trips sped up at the same time. Nurse Navigation encounters rose 50.9% from a year ago to 32,180, up from 28,909 in the second quarter. Meanwhile, emergency transports grew 3.3% from a year ago to 874,239, accelerating from 2.6% growth last quarter as GMR intentionally cut wheelchair rides by 62.8%.

What to watch: the number of new Nurse Navigation communities announced on the conference call. Adding four communities by year-end while keeping emergency transport growth above 2% would show the triage tool expands the business without cannibalizing core rides.

🟢 strengthening CAPITAL ALLOCATION

Debt Paydown Cut Interest Bills by One-Third

Following its May initial public offering, the medical transport group continued to clean up its balance sheet. On September 17, GMR completed a "repricing of its senior secured term loan due 2032 on September 17, 2026, which included the repayment of $200.0 million of senior secured term loan borrowings" and lowered the loan's interest rate by 0.5 percentage points.

That transaction brought total debt and lease reductions since December to $788.9 million by our math, leaving $4.41 billion on the balance sheet. Lower debt balances and cheaper rates cut third-quarter net interest expense by 36.5% from a year ago to $68.1 million, which saved $39.1 million in a single quarter and drove an 81.7% jump in net income.

What to watch: the company-defined net debt-to-EBITDA leverage ratio on the conference call. A reading below the second quarter's 3.5 times would keep the company on track for its 3.3 times year-end target.

🐻 Bear Case

🔴🔴 new GROWTH contradicts narrative

Unchanged Profit Target Leaves a Weak Fourth Quarter

"Combined with the momentum we are seeing in Nurse Navigation and new market growth, these results reinforce our confidence in the strength of our platform and opportunities ahead," Loporcaro said. Yet GMR trimmed the middle of its full-year revenue outlook by $60 million, to $5.975 billion, and kept its full-year Adjusted EBITDA range unchanged at $1.135 billion to $1.195 billion.

Because the third quarter used up $356.6 million of that annual profit budget, keeping the full-year ceiling unchanged leaves a small remainder for the final three months of the year. By our math, the middle of the updated outlook implies fourth-quarter revenue of $1,431.6 million, down 10.3% from the third quarter. It also implies fourth-quarter Adjusted EBITDA of $218.9 million, down 38.6% from the third quarter for a 15.3% margin.

Winter weather normally slows medical helicopter flights after the busy summer quarter, and late-2025 results included nearly $100 million of prior-period billing catch-ups that will not repeat. Even so, a 15.3% implied margin is 3.8 percentage points below the second quarter's 19.1% rate, cutting against management's message of steady platform momentum.

What to watch: fourth-quarter Adjusted EBITDA against the $218.9 million implied midpoint. A result near $219 million would mean winter seasonality and cost inflation erased the third quarter's margin gains.

🔴 persistent GOVERNANCE

Warrant Dilution Pushed Per-Share Profit Down 22%

While total operating profit rose, the amount earned for each share of stock excluding one-offs went down. During its May listing and recapitalization, GMR issued common stock and sold tens of millions of penny warrants — options to buy shares for almost nothing — to pay off high-cost preferred stock and debt.

Those warrants increased the diluted share count by 63.4% from a year ago to 242.4 million shares, including 145.4 million shares from warrants alone. As a result, Adjusted Diluted EPS (profit per share excluding one-offs and pre-IPO preferred stock costs) fell 22.0% from a year ago to $0.64. In addition, the balance sheet carries a $470.8 million tax receivable agreement liability that will send 85% of pre-IPO tax savings to majority owner KKR and insiders.

What to watch: the timing and dollar schedule of the first cash payments under the tax receivable agreement in the quarterly filing. Material cash payouts would reduce the free cash flow available to pay down the remaining $4.41 billion debt load.

🔴 persistent MACRO

Fuel Inflation and Weather Held Back Flights

External cost and volume pressures persisted across the helicopter and ground fleet. Tierney noted that third-quarter operations faced "weather-related pressure on flight activity, higher fuel and other inflationary costs, and the anticipated shift in payor mix" as expired government health-insurance subsidies pushed some patients off commercial plans.

  • Maintenance, fuel and other direct expenses: $150.0 million, up 25.1% from a year ago and up 1.4 percentage points of revenue to 9.4%
  • Weather cancellation rate for emergency flights: 15.7%, up from 14.8% a year ago and 15.5% in the second quarter
  • Total helicopter flights: 37,739, down 0.2% from a year ago despite emergent air requests rising 2.8%
  • Commercial insurance share of transport revenue: 57%, down from 59% a year ago, though up from 54% in the second quarter

Helicopter rides carry much higher prices than ground ambulances, so losing flights to bad weather while paying 25.1% more for maintenance and fuel squeezes profit. Commercial share rebounding from 54% in Q2 to 57% in Q3 suggests the insurance mix drag may be stabilizing, but one quarter does not settle the risk.

What to watch: commercial insurance share of transport revenue in the fourth quarter. Holding 56% to 57% for a second straight quarter would show the damage from expired exchange subsidies has stopped growing.

🔴 persistent DISCLOSURE

Risks This Quarter Didn't Answer

Several standing business and financial risks from the second quarter cannot be measured from the earnings release alone and await the conference call or quarterly Form 10-Q filing.

  • No Surprises Act billing adjustments: the release does not state how much revenue came from prior-period arbitration catch-ups versus the roughly $100 million headwind in the second half of 2025; the 10-Q revenue footnote will show it.
  • Company-defined net leverage: debt fell, but the exact net leverage multiple against the 3.3 times year-end target depends on lender-defined adjustments disclosed on the call.
  • Nurse Navigation footprint: encounters grew 50.9%, but the release does not state how many of the four planned communities opened toward the year-end target of 33.
  • Aircraft delivery delays: air bases rose by one from last quarter to 386, and the call will clarify whether supplier delays pushed more helicopter deliveries into 2027.

💲 Other KPIs

Free cash flow (26Q3) $110.3 million
⇗ accelerating

Cash left after capital spending rebounded in the third quarter. By our math, subtracting six-month figures from nine-month figures shows third-quarter operating cash flow of $195.0 million and property purchases of $84.7 million. That leaves $110.3 million of free cash flow, up 40.2% from $78.7 million a year ago after generating $79.3 million across the entire first half.

Accounts receivable, net (26Q3) $1,249.3 million
⇗ accelerating

Uncollected customer and insurer bills grew faster than sales for a second straight quarter. Net accounts receivable — money owed to the company for completed patient transports — rose 14.1% over the first nine months of 2026, and 7.1% in the third quarter alone, while nine-month net revenue grew 5.3%. That build absorbed $154.5 million of operating cash over nine months.

Capital and aircraft financing spend (26Q3) 5.1% of revenue
⇘ decelerating

Fleet and equipment spending slowed after a heavy second quarter. Cash used for net capital expenditures ($54.7 million) and aircraft financing ($27.5 million) totaled $82.2 million, or 5.1% of net revenue by our math. That stepped down from 6.3% in the second quarter and brought the nine-month rate to 5.6%.

🔮 Guidance

FY26 Net revenue $5,900–6,050 million
🠇 cut from $5,890–6,180 million
⇘ decelerating

Cut. The ambulance operator raised the bottom of its full-year revenue plan by $10 million and lowered the top by $130 million, trimming the middle of the range by $60 million to $5,975 million. By our math, subtracting nine-month revenue of $4,543.4 million leaves $1,431.6 million for the fourth quarter at the middle of the range, down 10.3% from the third quarter.

FY26 Adjusted EBITDA $1,135–1,195 million
🠆 unchanged from $1,135–1,195 million
⇘ decelerating

Unchanged. Management kept its full-year operating profit target excluding one-offs at a midpoint of $1,165 million for a third straight quarter. Because GMR already earned $946.1 million in the first nine months, the middle of the range leaves $218.9 million for the fourth quarter by our math, down 38.6% from the third quarter.

FY26 Cash used for net capex and aircraft financing (% of net revenue) 5.2–5.4%
🠅 raised from 5.1–5.3%
⇘ decelerating

Raised. The company lifted its full-year capital and aircraft spending budget by 0.1 percentage points at both ends, to a midpoint of 5.3% of revenue. Because spending ran at 5.6% in the first nine months ($255.1 million), hitting the middle of the full-year plan implies about $61.6 million, or 4.3% of revenue, in the fourth quarter by our math.

❓ Key Questions

Why does the outlook point to a 15% Q4 margin?

Third-quarter Adjusted EBITDA reached $356.6 million (22.3% margin), yet the unchanged full-year target leaves $218.9 million (15.3% margin) for Q4 at the midpoint. How much of that drop is normal winter air seasonality versus higher fuel or labor costs?

What was the prior-period billing adjustment in Q3?

In the first half of 2026, changes in revenue estimates from older No Surprises Act arbitration claims were $113.5 million lower than a year earlier. What was the dollar impact in Q3, and how much older claim inventory remains?

Where did net leverage finish the third quarter?

GMR paid down $200 million of its term loan in September and generated $110.3 million of Q3 free cash flow, but the implied Q4 EBITDA drop reduces trailing profit. What was Q3 net leverage, and does the below-3.3x year-end goal hold?

Why is accounts receivable growing twice as fast as sales?

Net accounts receivable rose 14.1% over nine months to $1,249.3 million while nine-month revenue rose 5.3%. Are health insurers slowing down arbitration payouts, or is the shift in insurance mix delaying collections?